Evaluation of lansoprazole as a probe for assessing cytochrome P450 2C19 activity and genotype–phenotype correlation in childhood

Impact of the CYP2C19*17 Allele on the Pharmacokinetics of Omeprazole and Pantoprazole in Children: Evidence for a Differential Effect

(2010) G. L. Kearns et al.   DRUG METABOLISM AND DISPOSITION

CYP2C19 activity comparison between Swedes and Koreans: effect of genotype, sex, oral contraceptive use, and smoking

(2010) Margareta Ramsjö et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Effects of CYP2C19, MDR1, and interleukin 1-B gene variants on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxicillin, and metronidazole

(2010) Barbara Gawrońska-Szklarz et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

[13C]-pantoprazole breath test to predict CYP2C19 phenotype and efficacy of a proton pump inhibitor, lansoprazole

(2009) T. FURUTA et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Oral Session III-C (OIII-C)Pharmacogenomics and Drug Disposition11:00 am - 12:00 pm

(2009)   CLINICAL PHARMACOLOGY & THERAPEUTICS

Association of CYP2B6, CYP3A5, and CYP2C19 Genetic Polymorphisms With Sibutramine Pharmacokinetics in Healthy Korean Subjects

(2009) K A Kim et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Polymorphism of human cytochrome P450 enzymes and its clinical impact

(2009) Shu-Feng Zhou et al.   DRUG METABOLISM REVIEWS

Rapid Identification of the Hepatic Cytochrome P450 2C19 Activity Using a Novel and Noninvasive [13C]Pantoprazole Breath Test

(2009) Z. Desta et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

CYP2C19*17 is associated with decreased breast cancer risk

(2008) Christina Justenhoven et al.   BREAST CANCER RESEARCH AND TREATMENT

Limited frequency of the CYP2C19*17 allele and its minor role in a Japanese population

(2008) Katsuyoshi Sugimoto et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers

(2008) R. Michael Baldwin et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Challenges for drug studies in children: CYP3A phenotyping as example

(2008) Saskia N. de Wildt et al.   DRUG DISCOVERY TODAY

Cytochrome P450 2C19 genetic polymorphisms in Ugandans

(2008) Jun Miura et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjects

(2008) Staffan Ohlsson Rosenborg et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Proton pump inhibitors: an update of their clinical use and pharmacokinetics

(2008) Shaojun Shi et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study

(2008) Jean-Philippe Collet et al.   LANCET

Genetic polymorphism analysis ofCYP2C19in Chinese Han populations from different geographic areas of mainland China

(2008) Lingling Chen et al.   PHARMACOGENOMICS

Need for reassessment of reportedCYP2C19allele frequencies in various populations in view ofCYP2C19*17discovery: the case of Greece

(2008) Georgia Ragia et al.   PHARMACOGENOMICS